Health Canada Warns of Fluid Balance Errors in Philips ICCA Software

Health Canada has issued a Type II health product recall notice for Philips Medizin Systeme Boblingen GmbH covering the IntelliSpace Critical Care and Anesthesia (ICCA) clinical information system. The notice, published on September 16, 2026, warns hospitals and critical care units that a software defect in two recent releases can generate inaccurate fluid balance calculations for patients under intensive monitoring.

The issue affects ICCA software versions J.06.01 and J.06.02. According to the notice, calculations triggered by infusion-pump auto-charting may produce incorrect Intake Totals, Output Totals, Net Body Balance, Length of Stay (LOS) Balance, and other related fluid-balance figures. These values are used by clinicians to track how much fluid a patient has received and eliminated over time, a calculation that plays a central role in managing critically ill patients.

Which Items Are Involved?

The recall applies specifically to the IntelliSpace Critical Care and Anesthesia platform, listed under Version J.06. No lot or serial numbers apply to this notice, as the issue is tied to the software version itself rather than to individual units or batches. The affected system is used in hospital critical care and anesthesia departments to manage patient monitoring and documentation.

What Went Wrong?

Health Canada explains that the defect is triggered only under a specific configuration. Facilities are affected only if they have set up and actively use ‘Auto Charting for Infusion Data’ for a Clinical Unit, with at least one of two settings enabled: automatic periodic charting of infusion rates and volumes, or automatic aperiodic charting of infusion rates and bolus volumes whenever a change occurs. Hospitals that have not configured either of these auto-charting settings are not affected by the issue, according to the notice.

Because fluid balance figures feed directly into clinical decision-making around hydration, medication dosing, and renal or cardiac management, even small calculation errors carry real consequences if they go unnoticed by care teams relying on the automated totals.

Who Should Be Concerned

The recall audience is listed as healthcare professionals rather than the general public, since ICCA is hospital-grade software rather than a consumer product. Critical care and anesthesia units in Canadian hospitals running the affected software versions, particularly those using the auto-charting features described above, are the ones directly impacted. Health Canada has not indicated that any patient harm has been confirmed, but the notice was issued to ensure affected facilities are aware of the discrepancy.

What Consumers Need to Do Now

Health Canada’s guidance for this notice is brief: facilities with questions or requiring further detail are directed to contact the manufacturer, Philips Medizin Systeme Boblingen GmbH, directly. Hospitals using the affected ICCA versions with auto-charting enabled should verify fluid balance totals against manual calculations where accuracy is critical, and should watch for further guidance or a software correction from Philips.

• Product: IntelliSpace Critical Care and Anesthesia, Version J.06
• Affected releases: J.06.01 and J.06.02
• Recall class: Type II
• Recall date: September 4, 2026
• Identification number: RA-82635
• Published by: Health Canada, audience listed as Healthcare

From the Agency

Health Canada published the notice under its medical devices recall and safety alert program, categorizing the issue under Anaesthesiology-related health products. The listing states plainly that the fix or resolution path is for affected customers to reach out to the manufacturer for additional information, rather than outlining a public product return or refund process, consistent with how software-based clinical system notices are typically handled.

As of the notice’s last update on September 16, 2026, no further corrective action details beyond contacting Philips had been published. Facilities are encouraged to monitor Health Canada’s recall and safety alerts database for any updates tied to identification number RA-82635.